nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—COMT—bipolar disorder	0.805	1	CbGaD
Methyldopa—DDC—telencephalic ventricle—bipolar disorder	0.0152	0.28	CbGeAlD
Methyldopa—COMT—telencephalic ventricle—bipolar disorder	0.01	0.185	CbGeAlD
Methyldopa—DDC—blood plasma—bipolar disorder	0.00724	0.133	CbGeAlD
Methyldopa—COMT—blood plasma—bipolar disorder	0.00478	0.0882	CbGeAlD
Methyldopa—ADRA2A—blood plasma—bipolar disorder	0.00244	0.0449	CbGeAlD
Methyldopa—COMT—adrenal cortex—bipolar disorder	0.00243	0.0448	CbGeAlD
Methyldopa—DDC—nervous system—bipolar disorder	0.00215	0.0397	CbGeAlD
Methyldopa—COMT—thyroid gland—bipolar disorder	0.00169	0.0312	CbGeAlD
Methyldopa—DDC—brain—bipolar disorder	0.00164	0.0303	CbGeAlD
Methyldopa—COMT—nervous system—bipolar disorder	0.00142	0.0262	CbGeAlD
Methyldopa—COMT—cerebellum—bipolar disorder	0.00134	0.0247	CbGeAlD
Methyldopa—COMT—brain—bipolar disorder	0.00109	0.02	CbGeAlD
Methyldopa—L-DOPA—DRD5—bipolar disorder	0.000907	0.133	CrCbGaD
Methyldopa—ADRA2A—thyroid gland—bipolar disorder	0.000861	0.0159	CbGeAlD
Methyldopa—Dopamine—DRD5—bipolar disorder	0.000843	0.123	CrCbGaD
Methyldopa—ADRA2A—nervous system—bipolar disorder	0.000725	0.0134	CbGeAlD
Methyldopa—ADRA2A—cerebellum—bipolar disorder	0.000682	0.0126	CbGeAlD
Methyldopa—DDC—SIDS Susceptibility Pathways—GRIN1—bipolar disorder	0.000652	0.00487	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—CPLX1—bipolar disorder	0.000647	0.00483	CbGpPWpGaD
Methyldopa—ADRA2A—Monoamine GPCRs—HTR1A—bipolar disorder	0.000601	0.00449	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—TPH2—bipolar disorder	0.000594	0.00443	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—TACR1—bipolar disorder	0.000594	0.00443	CbGpPWpGaD
Methyldopa—ADRA2A—Monoamine GPCRs—DRD1—bipolar disorder	0.000581	0.00433	CbGpPWpGaD
Methyldopa—ADRA2A—Monoamine GPCRs—HTR2C—bipolar disorder	0.000581	0.00433	CbGpPWpGaD
Methyldopa—ADRA2A—Monoamine GPCRs—DRD3—bipolar disorder	0.000562	0.0042	CbGpPWpGaD
Methyldopa—ADRA2A—brain—bipolar disorder	0.000554	0.0102	CbGeAlD
Methyldopa—ADRA2A—Monoamine GPCRs—DRD4—bipolar disorder	0.000546	0.00407	CbGpPWpGaD
Methyldopa—Dopamine—COMT—bipolar disorder	0.000532	0.0779	CrCbGaD
Methyldopa—DDC—Amino acid and derivative metabolism—TPH2—bipolar disorder	0.000512	0.00382	CbGpPWpGaD
Methyldopa—DDC—Amino acid and derivative metabolism—TSHB—bipolar disorder	0.000512	0.00382	CbGpPWpGaD
Methyldopa—ADRA2A—Monoamine GPCRs—DRD2—bipolar disorder	0.000509	0.00379	CbGpPWpGaD
Methyldopa—ADRA2A—Amine ligand-binding receptors—HTR1A—bipolar disorder	0.000505	0.00377	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.0005	0.00373	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—CLOCK—bipolar disorder	0.000498	0.00371	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—HTR1A—bipolar disorder	0.000492	0.00367	CbGpPWpGaD
Methyldopa—ADRA2A—Amine ligand-binding receptors—DRD1—bipolar disorder	0.000488	0.00364	CbGpPWpGaD
Methyldopa—ADRA2A—Amine ligand-binding receptors—HTR2C—bipolar disorder	0.000488	0.00364	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—GRIK2—bipolar disorder	0.000485	0.00362	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—TPH2—bipolar disorder	0.000485	0.00362	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—TAC1—bipolar disorder	0.000484	0.00361	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—SLC6A4—bipolar disorder	0.000475	0.00354	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—GATA3—bipolar disorder	0.000475	0.00354	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—SNAP25—bipolar disorder	0.000475	0.00354	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—GRIN1—bipolar disorder	0.000475	0.00354	CbGpPWpGaD
Methyldopa—ADRA2A—Amine ligand-binding receptors—DRD3—bipolar disorder	0.000473	0.00353	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—GAD1—bipolar disorder	0.000465	0.00347	CbGpPWpGaD
Methyldopa—L-DOPA—DRD4—bipolar disorder	0.000464	0.0679	CrCbGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—NTRK2—bipolar disorder	0.000462	0.00345	CbGpPWpGaD
Methyldopa—ADRA2A—Amine ligand-binding receptors—DRD4—bipolar disorder	0.000459	0.00342	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—CACNB2—bipolar disorder	0.000432	0.00323	CbGpPWpGaD
Methyldopa—Dopamine—DRD4—bipolar disorder	0.000431	0.0632	CrCbGaD
Methyldopa—ADRA2A—Amine ligand-binding receptors—DRD2—bipolar disorder	0.000428	0.00319	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—SLC5A3—bipolar disorder	0.000404	0.00302	CbGpPWpGaD
Methyldopa—Dopamine—MAOA—bipolar disorder	0.000401	0.0588	CrCbGaD
Methyldopa—ADRA2A—G alpha (z) signalling events—ADCY2—bipolar disorder	0.000401	0.00299	CbGpPWpGaD
Methyldopa—L-DOPA—DRD3—bipolar disorder	0.0004	0.0586	CrCbGaD
Methyldopa—L-DOPA—DRD1—bipolar disorder	0.000393	0.0575	CrCbGaD
Methyldopa—DDC—Circadian rythm related genes—DRD1—bipolar disorder	0.000388	0.00289	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—SLC6A4—bipolar disorder	0.000388	0.00289	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—DRD3—bipolar disorder	0.000376	0.0028	CbGpPWpGaD
Methyldopa—Dopamine—DRD3—bipolar disorder	0.000372	0.0545	CrCbGaD
Methyldopa—COMT—Neuronal System—GRIK2—bipolar disorder	0.000372	0.00277	CbGpPWpGaD
Methyldopa—ADRA2A—Regulation of insulin secretion—CACNB2—bipolar disorder	0.000369	0.00275	CbGpPWpGaD
Methyldopa—Dopamine—DRD1—bipolar disorder	0.000365	0.0535	CrCbGaD
Methyldopa—DDC—Circadian rythm related genes—DRD4—bipolar disorder	0.000365	0.00272	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—GRIN1—bipolar disorder	0.000364	0.00271	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.000358	0.00267	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.000357	0.00267	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—GAD1—bipolar disorder	0.000356	0.00266	CbGpPWpGaD
Methyldopa—ADRA2A—Monoamine GPCRs—HTR2A—bipolar disorder	0.000356	0.00266	CbGpPWpGaD
Methyldopa—Dopamine—SLC6A3—bipolar disorder	0.000346	0.0507	CrCbGaD
Methyldopa—COMT—Transmission across Chemical Synapses—SNAP25—bipolar disorder	0.000346	0.00258	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.000345	0.00257	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—DRD2—bipolar disorder	0.00034	0.00253	CbGpPWpGaD
Methyldopa—ADRA2A—Regulation of insulin secretion—CACNA1C—bipolar disorder	0.000337	0.00252	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—CACNB2—bipolar disorder	0.000331	0.00247	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—GRIN2B—bipolar disorder	0.000313	0.00233	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—SLC6A3—bipolar disorder	0.000308	0.0023	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—NTRK1—bipolar disorder	0.000308	0.00229	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—ADCY2—bipolar disorder	0.000306	0.00228	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.000305	0.00227	CbGpPWpGaD
Methyldopa—Dopamine—HTR1A—bipolar disorder	0.000303	0.0444	CrCbGaD
Methyldopa—ADRA2A—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.000299	0.00223	CbGpPWpGaD
Methyldopa—ADRA2A—Regulation of insulin secretion—SNAP25—bipolar disorder	0.000295	0.0022	CbGpPWpGaD
Methyldopa—COMT—Biological oxidations—MAOA—bipolar disorder	0.000293	0.00219	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.000291	0.00217	CbGpPWpGaD
Methyldopa—ADRA2A—Integration of energy metabolism—CACNB2—bipolar disorder	0.00029	0.00216	CbGpPWpGaD
Methyldopa—DDC—Metabolism—IMPA2—bipolar disorder	0.000285	0.00213	CbGpPWpGaD
Methyldopa—Norepinephrine—DRD2—bipolar disorder	0.000277	0.0405	CrCbGaD
Methyldopa—L-DOPA—DRD2—bipolar disorder	0.000277	0.0405	CrCbGaD
Methyldopa—ADRA2A—Integration of energy metabolism—CACNA1C—bipolar disorder	0.000265	0.00198	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—SNAP25—bipolar disorder	0.000265	0.00198	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—MAOA—bipolar disorder	0.00026	0.00194	CbGpPWpGaD
Methyldopa—Dopamine—SLC6A4—bipolar disorder	0.000259	0.0379	CrCbGaD
Methyldopa—Dopamine—DRD2—bipolar disorder	0.000257	0.0377	CrCbGaD
Methyldopa—COMT—Metabolism—IMPA2—bipolar disorder	0.000253	0.00189	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—DGKH—bipolar disorder	0.000246	0.00184	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—GRIN2B—bipolar disorder	0.00024	0.00179	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—SLC6A3—bipolar disorder	0.000236	0.00176	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—ADCY2—bipolar disorder	0.000234	0.00175	CbGpPWpGaD
Methyldopa—ADRA2A—Integration of energy metabolism—SNAP25—bipolar disorder	0.000232	0.00173	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—RGS4—bipolar disorder	0.00021	0.00157	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.000206	0.00153	CbGpPWpGaD
Methyldopa—ADRA2A—Integration of energy metabolism—ADCY2—bipolar disorder	0.000205	0.00153	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—SLC6A3—bipolar disorder	0.000203	0.00151	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—MAOA—bipolar disorder	0.000199	0.00149	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.000199	0.00148	CbGpPWpGaD
Methyldopa—DDC—Metabolism—IMPA1—bipolar disorder	0.000192	0.00144	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—GSK3B—bipolar disorder	0.000192	0.00143	CbGpPWpGaD
Methyldopa—COMT—Biological oxidations—POMC—bipolar disorder	0.000191	0.00143	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.000173	0.00129	CbGpPWpGaD
Methyldopa—COMT—Metabolism—IMPA1—bipolar disorder	0.000171	0.00127	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—TRPC3—bipolar disorder	0.000171	0.00127	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00017	0.00127	CbGpPWpGaD
Methyldopa—DDC—Metabolism—NDUFV2—bipolar disorder	0.000164	0.00122	CbGpPWpGaD
Methyldopa—DDC—Metabolism—AKR1C4—bipolar disorder	0.000158	0.00118	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000156	0.00116	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—SERPINA1—bipolar disorder	0.000149	0.00111	CbGpPWpGaD
Methyldopa—COMT—Metabolism—NDUFV2—bipolar disorder	0.000145	0.00108	CbGpPWpGaD
Methyldopa—ADRA2A—Regulation of insulin secretion—INS—bipolar disorder	0.000144	0.00107	CbGpPWpGaD
Methyldopa—DDC—Metabolism—NR1D1—bipolar disorder	0.000142	0.00106	CbGpPWpGaD
Methyldopa—COMT—Metabolism—AKR1C4—bipolar disorder	0.000141	0.00105	CbGpPWpGaD
Methyldopa—DDC—Metabolism—NCAN—bipolar disorder	0.000136	0.00102	CbGpPWpGaD
Methyldopa—DDC—Metabolism—SLC5A3—bipolar disorder	0.000133	0.000995	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—DRD5—bipolar disorder	0.00013	0.000968	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—DGKH—bipolar disorder	0.000127	0.000947	CbGpPWpGaD
Methyldopa—COMT—Metabolism—NR1D1—bipolar disorder	0.000126	0.000943	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—HTR1A—bipolar disorder	0.000125	0.000933	CbGpPWpGaD
Methyldopa—COMT—Metabolism—NCAN—bipolar disorder	0.000121	0.000902	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00012	0.000896	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00012	0.000896	CbGpPWpGaD
Methyldopa—COMT—Metabolism—SLC5A3—bipolar disorder	0.000118	0.000884	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—DRD3—bipolar disorder	0.000117	0.000873	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.000116	0.000866	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—DRD4—bipolar disorder	0.000114	0.000847	CbGpPWpGaD
Methyldopa—ADRA2A—Integration of energy metabolism—INS—bipolar disorder	0.000113	0.000843	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.000112	0.000836	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.000112	0.000836	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.000109	0.00081	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—ADCY2—bipolar disorder	0.000107	0.000797	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—DRD2—bipolar disorder	0.000106	0.000789	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.000105	0.000786	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000103	0.00077	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000102	0.000764	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—IMPA2—bipolar disorder	0.000101	0.00075	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	9.94e-05	0.000742	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	9.81e-05	0.000732	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	9.79e-05	0.00073	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CLOCK—bipolar disorder	9.64e-05	0.000719	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	9.6e-05	0.000716	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	9.6e-05	0.000716	CbGpPWpGaD
Methyldopa—DDC—Metabolism—TSHB—bipolar disorder	9.4e-05	0.000701	CbGpPWpGaD
Methyldopa—DDC—Metabolism—TPH2—bipolar disorder	9.4e-05	0.000701	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CACNB2—bipolar disorder	9.4e-05	0.000701	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—ADM—bipolar disorder	9.38e-05	0.0007	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	9.3e-05	0.000694	CbGpPWpGaD
Methyldopa—DDC—Metabolism—DPYD—bipolar disorder	9.24e-05	0.00069	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—TACR1—bipolar disorder	9.15e-05	0.000682	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—TSHB—bipolar disorder	9.15e-05	0.000682	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	9.03e-05	0.000674	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—TRPC3—bipolar disorder	8.8e-05	0.000656	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CACNA1C—bipolar disorder	8.59e-05	0.000641	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CLOCK—bipolar disorder	8.56e-05	0.000639	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	8.41e-05	0.000627	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PIK3C2A—bipolar disorder	8.37e-05	0.000625	CbGpPWpGaD
Methyldopa—COMT—Metabolism—TSHB—bipolar disorder	8.34e-05	0.000622	CbGpPWpGaD
Methyldopa—COMT—Metabolism—TPH2—bipolar disorder	8.34e-05	0.000622	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CACNB2—bipolar disorder	8.34e-05	0.000622	CbGpPWpGaD
Methyldopa—COMT—Metabolism—DPYD—bipolar disorder	8.21e-05	0.000612	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—DGKH—bipolar disorder	8.02e-05	0.000598	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SERPINA1—bipolar disorder	7.69e-05	0.000574	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CACNA1C—bipolar disorder	7.63e-05	0.000569	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—HTR1A—bipolar disorder	7.57e-05	0.000565	CbGpPWpGaD
Methyldopa—DDC—Metabolism—SNAP25—bipolar disorder	7.51e-05	0.00056	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—TAC1—bipolar disorder	7.46e-05	0.000556	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PIK3C2A—bipolar disorder	7.44e-05	0.000555	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—DRD5—bipolar disorder	7.34e-05	0.000547	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—HTR2C—bipolar disorder	7.31e-05	0.000546	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—DRD1—bipolar disorder	7.31e-05	0.000546	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—DGKH—bipolar disorder	7.28e-05	0.000543	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—RGS4—bipolar disorder	7.19e-05	0.000537	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—DRD3—bipolar disorder	7.08e-05	0.000528	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	6.87e-05	0.000513	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—DRD4—bipolar disorder	6.87e-05	0.000513	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—IMPA1—bipolar disorder	6.79e-05	0.000507	CbGpPWpGaD
Methyldopa—COMT—Metabolism—SNAP25—bipolar disorder	6.67e-05	0.000498	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—DRD5—bipolar disorder	6.66e-05	0.000497	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ADCY2—bipolar disorder	6.65e-05	0.000496	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—GATA3—bipolar disorder	6.54e-05	0.000488	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—RGS4—bipolar disorder	6.53e-05	0.000487	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—DRD2—bipolar disorder	6.4e-05	0.000478	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—POMC—bipolar disorder	5.92e-05	0.000441	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ADCY2—bipolar disorder	5.9e-05	0.00044	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	5.89e-05	0.000439	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NDUFV2—bipolar disorder	5.77e-05	0.000431	CbGpPWpGaD
Methyldopa—DDC—Metabolism—COMT—bipolar disorder	5.69e-05	0.000425	CbGpPWpGaD
Methyldopa—DDC—Metabolism—MAOA—bipolar disorder	5.65e-05	0.000422	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—AKR1C4—bipolar disorder	5.59e-05	0.000417	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—TRPC3—bipolar disorder	5.56e-05	0.000415	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ADM—bipolar disorder	5.3e-05	0.000396	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—TSHB—bipolar disorder	5.17e-05	0.000386	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PDE4B—bipolar disorder	5.17e-05	0.000386	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—TACR1—bipolar disorder	5.17e-05	0.000386	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—TRPC3—bipolar disorder	5.05e-05	0.000377	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NR1D1—bipolar disorder	5.02e-05	0.000375	CbGpPWpGaD
Methyldopa—COMT—Metabolism—MAOA—bipolar disorder	5.02e-05	0.000374	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ADM—bipolar disorder	4.82e-05	0.000359	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NCAN—bipolar disorder	4.8e-05	0.000358	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SLC5A3—bipolar disorder	4.71e-05	0.000351	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	4.7e-05	0.000351	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PDE4B—bipolar disorder	4.69e-05	0.00035	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—TSHB—bipolar disorder	4.69e-05	0.00035	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—TACR1—bipolar disorder	4.69e-05	0.00035	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—AKR1C4—bipolar disorder	4.68e-05	0.000349	CbGpPWpGaD
Methyldopa—DDC—Metabolism—MTHFR—bipolar disorder	4.6e-05	0.000343	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—HTR2A—bipolar disorder	4.48e-05	0.000335	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—DGKH—bipolar disorder	4.3e-05	0.000321	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR1A—bipolar disorder	4.28e-05	0.000319	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—TAC1—bipolar disorder	4.21e-05	0.000314	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—DRD1—bipolar disorder	4.13e-05	0.000308	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR2C—bipolar disorder	4.13e-05	0.000308	CbGpPWpGaD
Methyldopa—COMT—Metabolism—MTHFR—bipolar disorder	4.09e-05	0.000305	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—DRD3—bipolar disorder	4e-05	0.000299	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—DRD5—bipolar disorder	3.94e-05	0.000294	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR1A—bipolar disorder	3.88e-05	0.00029	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—DRD4—bipolar disorder	3.88e-05	0.00029	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—RGS4—bipolar disorder	3.86e-05	0.000288	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—TAC1—bipolar disorder	3.83e-05	0.000285	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR2C—bipolar disorder	3.75e-05	0.00028	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—DRD1—bipolar disorder	3.75e-05	0.00028	CbGpPWpGaD
Methyldopa—DDC—Metabolism—POMC—bipolar disorder	3.68e-05	0.000275	CbGpPWpGaD
Methyldopa—DDC—Metabolism—INS—bipolar disorder	3.66e-05	0.000273	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ADCY2—bipolar disorder	3.66e-05	0.000273	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—DRD3—bipolar disorder	3.63e-05	0.000271	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—DRD2—bipolar disorder	3.62e-05	0.00027	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—POMC—bipolar disorder	3.58e-05	0.000267	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—DRD4—bipolar disorder	3.53e-05	0.000263	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CLOCK—bipolar disorder	3.4e-05	0.000254	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ADCY2—bipolar disorder	3.32e-05	0.000248	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—TPH2—bipolar disorder	3.32e-05	0.000247	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—TSHB—bipolar disorder	3.32e-05	0.000247	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CACNB2—bipolar disorder	3.32e-05	0.000247	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—DRD2—bipolar disorder	3.29e-05	0.000245	CbGpPWpGaD
Methyldopa—COMT—Metabolism—POMC—bipolar disorder	3.27e-05	0.000244	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—DPYD—bipolar disorder	3.26e-05	0.000243	CbGpPWpGaD
Methyldopa—COMT—Metabolism—INS—bipolar disorder	3.25e-05	0.000242	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CACNA1C—bipolar disorder	3.03e-05	0.000226	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TRPC3—bipolar disorder	2.98e-05	0.000223	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PIK3C2A—bipolar disorder	2.96e-05	0.000221	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ADM—bipolar disorder	2.84e-05	0.000212	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PDE4B—bipolar disorder	2.77e-05	0.000207	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TACR1—bipolar disorder	2.77e-05	0.000207	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TSHB—bipolar disorder	2.77e-05	0.000207	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SNAP25—bipolar disorder	2.65e-05	0.000198	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR2A—bipolar disorder	2.53e-05	0.000189	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ADCY2—bipolar disorder	2.35e-05	0.000175	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR2A—bipolar disorder	2.3e-05	0.000172	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR1A—bipolar disorder	2.29e-05	0.000171	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TAC1—bipolar disorder	2.26e-05	0.000169	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR2C—bipolar disorder	2.22e-05	0.000165	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—DRD1—bipolar disorder	2.22e-05	0.000165	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NTRK2—bipolar disorder	2.16e-05	0.000161	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—DRD3—bipolar disorder	2.15e-05	0.00016	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GSK3A—bipolar disorder	2.14e-05	0.000159	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—DRD4—bipolar disorder	2.08e-05	0.000155	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—POMC—bipolar disorder	2.02e-05	0.000151	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—COMT—bipolar disorder	2.01e-05	0.00015	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MAOA—bipolar disorder	1.99e-05	0.000149	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ADCY2—bipolar disorder	1.96e-05	0.000146	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TCF7L2—bipolar disorder	1.95e-05	0.000146	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—DRD2—bipolar disorder	1.94e-05	0.000145	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—POMC—bipolar disorder	1.84e-05	0.000137	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NTRK1—bipolar disorder	1.76e-05	0.000131	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—S100B—bipolar disorder	1.71e-05	0.000127	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MTHFR—bipolar disorder	1.62e-05	0.000121	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NRG1—bipolar disorder	1.51e-05	0.000113	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR2A—bipolar disorder	1.36e-05	0.000101	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—POMC—bipolar disorder	1.3e-05	9.69e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—INS—bipolar disorder	1.29e-05	9.64e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GSK3B—bipolar disorder	1.09e-05	8.17e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—POMC—bipolar disorder	1.09e-05	8.1e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—INS—bipolar disorder	1.08e-05	8.06e-05	CbGpPWpGaD
